https://clinicaltrials.gov/ct2/show/NCT04077684?type=Intr&cond=Lupus&phase=012345&lupd_s=08%2F21%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus
Intervention : Drug: Interleukin-2
Sponsor : Peking University People’s Hospital
Not yet recruiting
Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial
NCT04077684
Wed, 04 Sep 2019 12:00:00 EDT
